|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-2
|
|
pubmed:abstractText |
Recent studies have shown that the pleiotropic cytokine hepatocyte growth factor/scatter factor (HGF/SF) and its receptor c-Met play major roles in the malignant progression of numerous tumors. For patients with breast cancer liver metastases, increased serum levels of HGF/SF have been reported. We studied the relationship between the clinical course of the disease and the serum levels of HGF/SF in such patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1010-4283
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
36-44
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17143015-Adult,
pubmed-meshheading:17143015-Aged,
pubmed-meshheading:17143015-Aged, 80 and over,
pubmed-meshheading:17143015-Breast Neoplasms,
pubmed-meshheading:17143015-Carcinoembryonic Antigen,
pubmed-meshheading:17143015-Disease Progression,
pubmed-meshheading:17143015-Female,
pubmed-meshheading:17143015-Hepatocyte Growth Factor,
pubmed-meshheading:17143015-Humans,
pubmed-meshheading:17143015-Liver Neoplasms,
pubmed-meshheading:17143015-Middle Aged,
pubmed-meshheading:17143015-Mucin-1,
pubmed-meshheading:17143015-Proto-Oncogene Proteins c-met,
pubmed-meshheading:17143015-Signal Transduction,
pubmed-meshheading:17143015-Tumor Markers, Biological
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Serum levels of hepatocyte growth factor/scatter factor in patients with liver metastases from breast cancer.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, University of Heidelberg Medical School, Heidelberg, Germany. Michael_Eichbaum@med.uni-heidelberg.de
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
